KIZ OpenIR  > 科研部门  > 肿瘤生物学(陈策实)
SGCE promotes breast cancer stemness by promoting the transcription of FGF-BP1 by Sp1
Qiu, T; Hou, L; Zhao, LN; Wang, XY; Zhou, ZM; Yang, CY; Zhang, HF; Jiang, DW; Jiao, BW; Chen, CS
2023
发表期刊JOURNAL OF BIOLOGICAL CHEMISTRY
卷号299期号:11
摘要Breast cancer stem cells are mainly responsible for poor prognosis, especially in triple-negative breast cancer (TNBC). In a previous study, we demonstrated that e-Sarcoglycan (SGCE), a type I single-transmembrane protein, is a potential oncogene that promotes TNBC stemness by stabilizing EGFR. Here, we further found that SGCE depletion reduces breast cancer stem cells, partially through inhibiting the transcription of FGF-BP1, a secreted oncoprotein. Mechanistically, we demonstrate that SGCE could interact with the specific protein 1 transcription factor and translocate into the nucleus, which leads to an increase in the transcription of FGF-BP1, and the secreted FBF-BP1 activates FGF-FGFR signaling to promote cancer cell stemness. The novel SGCE-Sp1-FGF-BP1 axis provides novel potential candidate diagnostic markers and therapeutic targets for TNBC.
收录类别SCI
语种英语
文献类型期刊论文
条目标识符http://ir.kiz.ac.cn/handle/152453/14190
专题科研部门_肿瘤生物学(陈策实)
推荐引用方式
GB/T 7714
Qiu, T,Hou, L,Zhao, LN,et al. SGCE promotes breast cancer stemness by promoting the transcription of FGF-BP1 by Sp1[J]. JOURNAL OF BIOLOGICAL CHEMISTRY,2023,299(11).
APA Qiu, T.,Hou, L.,Zhao, LN.,Wang, XY.,Zhou, ZM.,...&Chen, CS.(2023).SGCE promotes breast cancer stemness by promoting the transcription of FGF-BP1 by Sp1.JOURNAL OF BIOLOGICAL CHEMISTRY,299(11).
MLA Qiu, T,et al."SGCE promotes breast cancer stemness by promoting the transcription of FGF-BP1 by Sp1".JOURNAL OF BIOLOGICAL CHEMISTRY 299.11(2023).
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
2024061201.pdf(4382KB)期刊论文出版稿开放获取CC BY-NC-SA请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Qiu, T]的文章
[Hou, L]的文章
[Zhao, LN]的文章
百度学术
百度学术中相似的文章
[Qiu, T]的文章
[Hou, L]的文章
[Zhao, LN]的文章
必应学术
必应学术中相似的文章
[Qiu, T]的文章
[Hou, L]的文章
[Zhao, LN]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。